Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 1
2016 1
2017 4
2019 2
2020 1
2021 1
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab biosimilar-induced lupus nephritis: A case report.
Shidahara K, Katsuyama T, Hirose K, Matsumoto K, Nawachi S, Nakadoi T, Asano Y, Katayama Y, Miyawaki Y, Katsuyama E, Takano-Narazaki M, Matsumoto Y, Sada KE, Wada J. Shidahara K, et al. Among authors: takano narazaki m. Mod Rheumatol Case Rep. 2023 Dec 29;8(1):74-76. doi: 10.1093/mrcr/rxad061. Mod Rheumatol Case Rep. 2023. PMID: 37902434
The Association of Grit With Burnout Components (Professional Efficacy, Exhaustion, and Cynicism) Among Academic Rheumatologists: The TRUMP 2 -SLE Study.
Miyawaki Y, Sada KE, Shidahara K, Nawachi S, Asano Y, Katayama Y, Hayashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Yajima N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Ichikawa T, Kishida D, Shimojima Y, Wada J, Kurita N. Miyawaki Y, et al. Among authors: takano narazaki m. J Clin Rheumatol. 2023 Sep 1;29(6):268-274. doi: 10.1097/RHU.0000000000001989. Epub 2023 May 25. J Clin Rheumatol. 2023. PMID: 37226300
Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study.
Sada KE, Katayama Y, Asano Y, Hayashi K, Miyawaki Y, Ohashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yajima N. Sada KE, et al. Among authors: takano narazaki m. Lupus Sci Med. 2022 Sep;9(1):e000772. doi: 10.1136/lupus-2022-000772. Lupus Sci Med. 2022. PMID: 36167483 Free PMC article.
Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus.
Sada KE, Miyawaki Y, Shidahara K, Nawachi S, Katayama Y, Asano Y, Hayashi K, Ohashi K, Katsuyama E, Katsuyama T, Takano-Narazaki M, Matsumoto Y, Oguro N, Ishikawa Y, Sakurai N, Hidekawa C, Yoshimi R, Kishida D, Ichikawa T, Shimojima Y, Kurita N, Yajima N. Sada KE, et al. Among authors: takano narazaki m. Rheumatology (Oxford). 2023 Jun 1;62(6):2154-2159. doi: 10.1093/rheumatology/keac612. Rheumatology (Oxford). 2023. PMID: 36264112
The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.
Matsuo S, Hayashi K, Morimoto E, Kato A, Sada KE, Watanabe H, Takano-Narazaki M, Sunahori-Watanabe K, Kawabata T, Wada J. Matsuo S, et al. Among authors: takano narazaki m. Intern Med. 2017;56(11):1435-1438. doi: 10.2169/internalmedicine.56.8235. Epub 2017 Jun 1. Intern Med. 2017. PMID: 28566612 Free PMC article.
Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.
Miyawaki Y, Shimizu S, Ogawa Y, Sada KE, Katayama Y, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Ohashi K, Morishita M, Watanabe H, Takano-Narazaki M, Matsumoto Y, Yajima N, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yamazaki H, Yamamoto Y, Wada J, Fukuhara S. Miyawaki Y, et al. Among authors: takano narazaki m. Arthritis Res Ther. 2021 Mar 10;23(1):79. doi: 10.1186/s13075-021-02466-2. Arthritis Res Ther. 2021. PMID: 33691746 Free PMC article.
Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib.
Yamamura Y, Matsumoto Y, Asano Y, Katayama Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Takano-Narazaki M, Sada KE, Wada J. Yamamura Y, et al. Among authors: takano narazaki m. Rheumatol Adv Pract. 2019 Dec 23;4(1):rkz050. doi: 10.1093/rap/rkz050. eCollection 2020. Rheumatol Adv Pract. 2019. PMID: 32016168 Free PMC article. No abstract available.
Immunosuppressive Treatment for an anti-U1 Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension.
Matsumoto K, Miyawaki Y, Katsuyama T, Nakadoi T, Shidahara K, Hirose K, Nawachi S, Asano Y, Katayama Y, Katsuyama E, Takano-Narazaki M, Matsumoto Y, Mori A, Akagi S, Sada KE, Wada J. Matsumoto K, et al. Among authors: takano narazaki m. Intern Med. 2024 Mar 1;63(5):671-676. doi: 10.2169/internalmedicine.1407-22. Epub 2023 Jul 19. Intern Med. 2024. PMID: 37468249 Free PMC article.
Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Morishita M, Watanabe H, Yan M, Zeggar S, Hiramatsu S, Ohashi K, Miyawaki Y, Katsuyama E, Katsuyama T, Takano Narazaki M, Toyota Tatebe N, Sunahori Watanabe K, Kawabata T, Sada KE, Wada J. Morishita M, et al. Among authors: takano narazaki m. Intern Med. 2017;56(13):1645-1650. doi: 10.2169/internalmedicine.56.8287. Epub 2017 Jul 1. Intern Med. 2017. PMID: 28674351 Free PMC article.
16 results